Stockreport

PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights

PMV Pharmaceuticals, Inc.  (PMVP) 
PDF Registrational, tumor-agnostic Phase 2 portion of PYNNACLE clinical trial of rezatapopt (PC14586), a first-in-class precision oncology investigational therapy in patient [Read more]